Leptin responsiveness restored by amylin agonism in diet-induced obesity: Evidence from nonclinical and clinical studiesJonathan D. Roth, Alain Baron, Barbara Roland et al.|Proceedings of the National Academy of Sciences|2008Cited by 433
Glucagon-like peptide-1 receptor agonism improves metabolic, biochemical, and histopathological indices of nonalcoholic steatohepatitis in miceJames L. Trevaskis, Jonathan D. Roth, Peter S. Griffin et al.|American Journal of Physiology-Gastrointestinal and Liver Physiology|2012Cited by 278
Amylin-Mediated Restoration of Leptin Responsiveness in Diet-Induced Obesity: Magnitude and MechanismsJames L. Trevaskis, Jonathan D. Roth, Todd Coffey et al.|Endocrinology|2008Cited by 150
Mechanisms of Amylin/Leptin Synergy in Rodent ModelsVictoria F. Turek, Jonathan D. Roth, Calvin Vu et al.|Endocrinology|2009Cited by 136
Davalintide (AC2307), a novel amylin-mimetic peptide: enhanced pharmacological properties over native amylin to reduce food intake and body weightChristine M. Mack, David G. Parkes, Carlos José Soares et al.|International Journal of Obesity|2009Cited by 112